The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms

Why It Matters

Employers and health plans spend billions on MSK treatment; without durable outcomes, AI investments risk inflating costs rather than reducing them. Aligning AI with resolution‑focused models could unlock genuine savings and better health results.

Key Takeaways

• AI improves workflow but not clinical outcomes in MSK care
• Engagement metrics miss employer priorities like surgery deflection
• Physical tissue damage requires clinician intervention beyond digital guidance
• Scaling partial care increases volume without reducing total cost
• Future breakthroughs need outcome‑accountable models with AI as support

Pulse Analysis

Artificial intelligence has undeniably streamlined many administrative burdens in healthcare. Ambient listening tools and generative documentation reduce screen time, allowing clinicians to focus on patient interaction. However, these efficiencies address only the mechanics of care delivery. The real test for AI lies in whether it can influence the clinical trajectory of conditions that demand more than virtual guidance. In musculoskeletal medicine, where tissue repair often requires hands‑on treatment, AI‑driven platforms excel at tracking engagement but fall short of delivering lasting health improvements.

MSK disorders represent roughly 17% of every healthcare dollar spent by employer‑sponsored plans, making them a prime target for digital health investment. Vendors now market impressive usage statistics—daily logins, exercise adherence, chat interactions—but insurers and corporate buyers evaluate success by surgery avoidance, reduced imaging, and overall cost of care. This misalignment creates a "resolution gap": high digital engagement coexists with persistent, costly episodes of care. As AI continues to automate intake and triage, the risk is that faster referral cycles simply funnel more patients into traditional, high‑cost interventions without lowering the underlying expense.

The path forward calls for outcome‑accountable care models that embed AI as an augmentation rather than a replacement. Clinicians must retain responsibility for functional restoration, using AI to inform decision‑making, personalize rehab protocols, and monitor progress. For investors and health plans, backing platforms that tie reimbursement to measurable recovery metrics—rather than mere app usage—will drive both clinical value and financial returns. In this framework, AI becomes a catalyst for genuine cost reduction and improved patient outcomes, fulfilling its promise beyond operational convenience.